具核梭杆菌与口腔鳞状细胞癌关系的研究进展

doi:10.13591/j.cnki.kqyx.2023.06.012

摘要/Abstract

摘要：

具核梭杆菌(Fusobacterium nucleatum,Fn)作为人类口腔微生态的常驻菌群,已被证实为牙周炎的主要致病菌,参与牙周病的发生发展。近年来,大量证据表明,Fn负载的增加与口腔鳞状细胞癌(oral squamous cell carcinoma,OSCC)的发展和预后关系密切。Fn可能通过增强肿瘤细胞增殖、侵袭迁移能力及耐药性等多种肿瘤生物学特性,促进OSCC的发生发展。此外,以Fn为靶标的靶向治疗策略为OSCC的防治提供了新思路。本文综述了Fn促进OSCC发生发展相关的潜在机制,并对OSCC的Fn靶向治疗进行总结与展望,以期为OSCC的防治提供新的理论基础。

关键词: 具核梭杆菌, 口腔鳞状细胞癌, 增殖, 侵袭转移, 耐药性

Abstract:

Fusobacterium nucleatum(Fn), as the resident flora of human oral microecology, has been proved to be the main pathogen of periodontitis, participating in the occurrence and development of periodontal disease. In recent years, a large amount of evidence shows that the increase of Fn load is closely related to the development and prognosis of oral squamous cell carcinoma(OSCC). Fn may promote the occurrence and development of OSCC by enhancing tumor cell proliferation, invasion and migration ability and drug resistance. In addition, the targeted therapy targeting at Fn provides a new idea for the prevention and treatment of OSCC. In this paper, the potential mechanism of Fn promoting the occurrence and development of OSCC is reviewed, and the Fn targeted therapy of OSCC is summarized and prospected, so as to provide a new theoretical basis for the prevention and treatment of OSCC.

Key words: Fusobacterium nucleatum, oral squamous cell carcinoma, proliferation, invasion and migration, drug resistance

中图分类号:

R739.85

徐依萍, 黄嘉玲, 刘忠斌, 杨琨, 葛颂. 具核梭杆菌与口腔鳞状细胞癌关系的研究进展[J]. 口腔医学, 2023, 43(6): 546-551.

XU Yiping, HUANG Jialing, LIU Zhongbin, YANG Kun, GE Song. Research progress of the relationship between Fusobacterium nucleatum and oral squamous cell carcinoma[J]. Stomatology, 2023, 43(6): 546-551.

图/表 1

参考文献 52

[1]	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249. doi: 10.3322/caac.v71.3
[2]	Bagan J, Sarrion G, Jimenez Y. Oral cancer: Clinical features[J]. Oral Oncol, 2010, 46(6):414-417. doi: 10.1016/j.oraloncology.2010.03.009 pmid: 20400366
[3]	Yang GJ, Yang YX, Tang H, et al. Loss of the clock gene Per1 promotes oral squamous cell carcinoma progression via the AKT/mTOR pathway[J]. Cancer Sci, 2020, 111(5):1542-1554. doi: 10.1111/cas.v111.5
[4]	Kakabadze MZ, Paresishvili T, Karalashvili L, et al. Oral microbiota and oral cancer: Review[J]. Oncol Rev, 2020, 14(2):476. doi: 10.4081/oncol.2020.476 pmid: 32676172
[5]	孟焕新. 牙周病学[M]. 5版. 北京: 人民卫生出版社, 2020.
[6]	Nagy KN, SonkodiI, Szöke I, et al. The microflora associated with human oral carcinomas[J]. Oral Oncol, 1998, 34(4):304-308. pmid: 9813727
[7]	Chang CR, Geng FX, Shi XT, et al. The prevalence rate of periodontal pathogens and its association with oral squamous cell carcinoma[J]. Appl Microbiol Biotechnol, 2019, 103(3):1393-1404. doi: 10.1007/s00253-018-9475-6 pmid: 30470868
[8]	Bronzato JD, Bomfim RA, Edwards DH, et al. Detection of Fusobacterium in oral and head and neck cancer samples: A systematic review and meta-analysis[J]. Arch Oral Biol, 2020, 112: 104669. doi: 10.1016/j.archoralbio.2020.104669
[9]	Zhang L, Liu Y, Zheng HJ, et al. The oral microbiota may have influence on oral cancer[J]. Front Cell Infect Microbiol, 2020, 9: 476. doi: 10.3389/fcimb.2019.00476
[10]	Yost S, Stashenko P, Choi Y, et al. Increased virulence of the oral microbiome in oral squamous cell carcinoma revealed by metatranscriptomeanalyses[J]. Int J Oral Sci, 2018, 10(4):32. doi: 10.1038/s41368-018-0037-7
[11]	Yang CY, Yeh YM, Yu HY, et al. Oral microbiota community dynamics associated with oral squamous cell carcinoma staging[J]. Front Microbiol, 2018, 9: 862. doi: 10.3389/fmicb.2018.00862
[12]	Zhao HS, Chu M, Huang ZW, et al. Variations in oral microbiota associated with oral cancer[J]. Sci Rep, 2017, 7(1):11773. doi: 10.1038/s41598-017-11779-9 pmid: 28924229
[13]	Geng FX, Zhang YJ, Lu Z,et al. Fusobacterium nucleatum caused DNA damage and promoted cell proliferation by the Ku70/p53 pathway in oral cancer cells[J]. DNA Cell Biol, 2020, 39(1):144-151. doi: 10.1089/dna.2019.5064
[14]	Hsueh CY, Lau HC, Huang Q,et al. Fusobacterium nucleatum impairs DNA mismatch repair and stability in patients with squamous cell carcinoma of the head and neck[J]. Cancer, 2022, 128(17):3170-3184. doi: 10.1002/cncr.v128.17
[15]	Yang YZ, Weng WH, Peng JJ, et al. Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating toll-like receptor 4 signaling to nuclear factor-κB, and up-regulating expression of microRNA-21[J]. Gastroenterology, 2017, 152(4):851-866.e24. doi: 10.1053/j.gastro.2016.11.018
[16]	Komiya Y, Shimomura Y, Higurashi T, et al. Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity[J]. Gut, 2019, 68(7):1335-1337. doi: 10.1136/gutjnl-2018-316661
[17]	Harrandah AM, Chukkapalli SS, Bhattacharyya I,et al. Fusobacteria modulate oral carcinogenesis and promote cancer progression[J]. J Oral Microbiol, 2021, 13(1):1849493. doi: 10.1080/20002297.2020.1849493
[18]	Nazar M, Naz I, Mahmood MK, et al. Immunohistochemical expression of Cyclin D1 and ki-67 in primary and metastatic oral squamous cell carcinoma[J]. Asian Pac J Cancer Prev, 2020, 21(1):37-41. doi: 10.31557/APJCP.2020.21.1.37
[19]	Ramos-García P, González-Moles MÁ, González-Ruiz L, et al. Clinicopathological significance of tumor Cyclin D1 expression in oral cancer[J]. Arch Oral Biol, 2019, 99: 177-182. doi: S0003-9969(18)30853-7 pmid: 30721793
[20]	Rubinstein MR, Baik JE, Lagana SM,et al. Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β-catenin modulator AnnexinA1[J]. EMBO Rep, 2019, 20(4):e47638. doi: 10.15252/embr.201847638
[21]	Han ZH, Wang F, Wang FL, et al. Regulation of transforming growth factor β-mediated epithelial-mesenchymal transition of lens epithelial cells by c-Src kinase under high glucose conditions[J]. ExpTher Med, 2018, 16(2):1520-1528.
[22]	Zhang P, Dai H, Peng L. AGEs induce epithelial to mesenchymal transformation of human peritoneal mesothelial cells via upregulation of STAT3[J]. Glycoconj J, 2019, 36(2):155-163. doi: 10.1007/s10719-019-09861-7
[23]	Vyhnalova T, Danek Z, Gachova D, et al. The role of the oral microbiota in the etiopathogenesis of oral squamous cell carcinoma[J]. Microorganisms, 2021, 9(8):1549. doi: 10.3390/microorganisms9081549
[24]	Da JS, Wang XQ, Li L,et al. Fusobacterium nucleatum promotes cisplatin-resistance and migration of oral squamous carcinoma cells by up-regulating Wnt5a-mediated NFATc₃expression[J]. Tohoku J Exp Med, 2021, 253(4):249-259. doi: 10.1620/tjem.253.249
[25]	Xu YM, Jiang EH, Shao Z, et al. Long noncoding RNAs in the metastasis of oral squamous cell carcinoma[J]. Front Oncol, 2021, 10: 616717. doi: 10.3389/fonc.2020.616717
[26]	张树伟. 具核梭杆菌通过lncRNA MIR4435-2HG/miR-296-5p/Akt2/SNAI1信号通路促进口腔上皮细胞发生上皮间充质转化[D]. 沈阳: 中国医科大学, 2020.
[27]	Shao WH, Fujiwara N, Mouri Y, et al. Conversion from epithelial to partial-EMT phenotype by Fusobacterium nucleatum infection promotes invasion of oral cancer cells[J]. Sci Rep, 2021, 11(1):14943. doi: 10.1038/s41598-021-94384-1
[28]	Saitoh M. Involvement of partial EMT in cancer progression[J]. J Biochem, 2018, 164(4):257-264. doi: 10.1093/jb/mvy047 pmid: 29726955
[29]	Bui FQ, Johnson L, Roberts J,et al. Fusobacterium nucleatum infection of gingival epithelial cells leads to NLRP3 inflammasome-dependent secretion of IL-1β and the danger signals ASC and HMGB1[J]. Cell Microbiol, 2016, 18(7):970-981. doi: 10.1111/cmi.12560
[30]	Lee CH, Chang JSM, Syu SH, et al. IL-1β promotes malignant transformation and tumor aggressiveness in oral cancer[J]. J Cell Physiol, 2015, 230(4):875-884. doi: 10.1002/jcp.v230.4
[31]	Uitto VJ, Baillie D, Wu Q,et al. Fusobacterium nucleatum increases collagenase 3 production and migration of epithelial cells[J]. Infect Immun, 2005, 73(2):1171-1179. doi: 10.1128/IAI.73.2.1171-1179.2005
[32]	Johansson N, Airola K, Grénman R, et al. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck[J]. Am J Pathol, 1997, 151(2):499-508. pmid: 9250162
[33]	Lau A, Li KY, Yang WF, et al. Induction chemotherapy for squamous cell carcinomas of the oral cavity: A cumulative meta-analysis[J]. Oral Oncol, 2016, 61: 104-114. doi: 10.1016/j.oraloncology.2016.08.022 pmid: 27688112
[34]	Devarajan N, Manjunathan R, Ganesan SK. Tumor hypoxia: The major culprit behind cisplatin resistance in cancer patients[J]. Crit Rev Oncol, 2021, 162: 103327. doi: 10.1016/j.critrevonc.2021.103327
[35]	Sun ZJ, Luo QQ, Ye DX, et al. Role of toll-like receptor 4 on the immune escape of human oral squamous cell carcinoma and resistance of cisplatin-induced apoptosis[J]. Mol Cancer, 2012, 11: 33. doi: 10.1186/1476-4598-11-33 pmid: 22583829
[36]	Liu Y, Baba Y, Ishimoto T,et al. Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma[J]. Br J Cancer, 2021, 124(5):963-974. doi: 10.1038/s41416-020-01198-5
[37]	Morimoto H, Yano T, Yoda Y, et al. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma[J]. World J Gastroenterol, 2017, 23(6):1051-1058. doi: 10.3748/wjg.v23.i6.1051
[38]	刁伟斌, 吴秀平, 游巧玲. 奥硝唑与替硝唑以及甲硝唑在口腔治疗的应用及药效对比研究[J]. 海峡药学, 2021, 33(2):139-140.
[39]	Bullman S, Pedamallu CS, Sicinska E, et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer[J]. Science, 2017, 358(6369):1443-1448. doi: 10.1126/science.aal5240 pmid: 29170280
[40]	Parhi L, Alon-Maimon T, Sol A, et al. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression[J]. Nat Commun, 2020, 11(1):3259. doi: 10.1038/s41467-020-16967-2
[41]	McIlvanna E, Linden GJ, Craig SG,et al. Fusobacterium nucleatum and oral cancer: A critical review[J]. BMC Cancer, 2021, 21(1):1212. doi: 10.1186/s12885-021-08903-4 pmid: 34774023
[42]	Chen YT, Hsieh PS, Ho HH, et al. Antibacterial activity of viable and heat-killed probiotic strains against oral pathogens[J]. Lett Appl Microbiol, 2020, 70(4):310-317. doi: 10.1111/lam.13275 pmid: 31955445
[43]	孔祥丽, 马岩石, 吴昕雨, 等. 苯乳酸对具核梭杆菌的抑菌效果及机制[J]. 食品科学, 2022, 43(7):38-44.
[44]	Kamarajan P, Ateia I, Shin JM, et al. Periodontal pathogens promote cancer aggressivity via TLR/MyD88 triggered activation of Integrin/FAK signaling that is therapeutically reversible by a probiotic bacteriocin[J]. PLoS Pathog, 2020, 16(10):e1008881. doi: 10.1371/journal.ppat.1008881
[45]	张环, 尹利娟, 陆瑜, 等. 益生菌在口腔中的应用研究[J]. 口腔护理用品工业, 2021, 31(2):18-20.
[46]	Zhang ZY, Liu S, Zhang SW,et al. Porphyromonas gingivalis outer membrane vesicles inhibit the invasion of Fusobacterium nucleatum into oral epithelial cells by downregulatingFadA and FomA[J]. J Periodontol, 2022, 93(4):515-525. doi: 10.1002/jper.v93.4
[47]	Gur C, Ibrahim Y, Isaacson B, et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack[J]. Immunity, 2015, 42(2):344-355. doi: 10.1016/j.immuni.2015.01.010
[48]	Wang JG, Song RY, Wang CM, et al. MiR-195 inhibits proliferation and enhances apoptosis of OSCC cells via targeting TLR4[J]. J Healthc Eng, 2022, 2022: 2270777.
[49]	Łusiak-Szelachowska M, Weber-Dᶏbrowska B, Górski A. Bacteriophages and lysins in biofilm control[J]. Virol Sin, 2020, 35(2):125-133. doi: 10.1007/s12250-019-00192-3 pmid: 32125643
[50]	Szafrański SP, Winkel A, Stiesch M. The use of bacteriophages to biocontrol oral biofilms[J]. J Biotechnol, 2017, 250: 29-44. doi: S0168-1656(17)30011-1 pmid: 28108235
[51]	Kabwe M, Brown TL, Dashper S, et al. Genomic, morphological and functional characterisation of novel bacteriophage FNU₁ capable of disrupting Fusobacterium nucleatum biofilms[J]. Sci Rep, 2019, 9(1):9107. doi: 10.1038/s41598-019-45549-6
[52]	Akturk E, Oliveira H, Santos SB, et al. Synergistic action of phage and antibiotics: Parameters to enhance the killing efficacy against mono and dual-species biofilms[J]. Antibiotics (Basel), 2019, 8(3):103.